Short interest for Beneficient gives investors a sense of the degree to which investors are betting on the decline of Beneficient's stock. Short interest data is updated every two weeks.

Beneficient Stock (NASDAQ:BENF), Short Interest Report

Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

stock-624712

News

BENF

Beneficient shares are trading higher by 290% during Friday&#39;s session. The company announced it regained compliance with the Nasdaq.

Why Beneficient (BENF) Shares Are Exploding Higher

Earnings

Markets

Movers

AGBA

AILE

ALRN

APOG

BPTH

EDBL

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INVO

NRXP

OCUL

SINT

SMSI

SMXT

SPCB

THCH

TIRX

TLSA

TOON

VTNR

WINT

WISA

WRNT

XPON

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Penny Stocks

Small Cap

Intraday Update

Trading Ideas

ACDC

ADXN

BACK

BNED

BSGM

CGEM

CLDI

CSLR

CTNM

DFLI

DYNT

ERIC

ITCI

JAGX

KAVL

MCBC

MNSO

PACB

PALI

PRFX

PRSO

PRZO

RNAC

RVYL

SKIL

SPRC

SXTC

SYTA

TAOP

WFTC

Shares of  Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates.

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Flanigan'S Enterprises (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BDL#AMEX">BDL</a>) reported quarterly earnings of $1.04 per share. This is a 1.96 percent increase over earnings of $1.02 per share from the same period last year. The company reported $48.07 million in sales this quarter. This is a 9.74 percent increase over sales of $43.80 million the same period last year.

Flanigan'S Enterprises Q2 EPS $1.04 Up From $1.02 YoY, Sales $48.07M Up From $43.80M YoY

WIIM

NFLX

Netflix shares are trading higher on reports the company has reached 40 million global MAUs on its ad-supported plan. It was also reported the company will launch an in-house advertising program by the end of 2025.

Truist Securities initiated coverage on Integer Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ITGR#NYSE">ITGR</a>), noting the company as one of <a href="https://www.benzinga.com/insights/analyst-ratings/24/05/38851647/beyond-the-numbers-7-analysts-discuss-integer-holdings-stock">the largest med device</a> outsource manufacturers and a unique SMID MedTech asset.
The analyst notes Integer&#8217;s profitability and leveraged EPS growth prospects (1.5-2x that of revenue), which can sustain a high-teens 2023-2026 EPS CAGR.
Integer has increasing exposure (through the OEM supply chain) to growth segments &amp; emerging product cycles across the MedTech sector, Truist writes.
Also, a durable inorganic (tuck-in) strategy can add at least 1-2%+ on top of a high-single-digit organic top-line, the analyst adds.
Related: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38256857/medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-mar">Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA</a>.
Truist initiates with a Buy rating and a&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/ITGR/analyst-ratings" rel="noreferrer noopener">price target of $137</a>.
Integer has an 18 to 20 percent share in its served markets, which total about $9 billion. The trend is toward increased manufacturer outsourcing as the industry seeks to reduce costs and add redundancy.
Truist notes that the &#8220;med device outsourcing sector is ripe for a player like Integer to drive consolidation as it leverages its growing scale within a highly fragmented market.&#8221;
Truist projects Integer to achieve 8-9% organic revenue growth, surpassing its weighted average market growth rate of 4%-6%, driven by the company&#8217;s strategic shift towards faster-growing markets, increased market share, and advantages of scale in a consolidating med device outsourcing industry.&nbsp;
Additionally, with an annual M&amp;A budget of $250-300 million, the analyst expects an additional 200 basis points of growth per year.
In April, Integer reported first-quarter adjusted EPS of $1.14, beating the consensus of $1.11. Sales were $414.81 million, up 10% (organic growth of 6%), beating the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38428155/integer-holdings-corporation-reports-first-quarter-2024-results" rel="noreferrer noopener">consensus of $412.83 million</a>.
Price Action: ITGR shares are up 4.76% at $117.34 at last check Wednesday.
Now Read: <a href="https://www.benzinga.com/news/management/24/05/38853075/ryan-cohens-wealth-soars-on-gamestop-stock-rally-how-much-is-video-game-retailer-ceo-worth">Ryan Cohen&#8217;s Wealth Soars On GameStop Stock Rally: How Much Is Video Game Retailer CEO Worth?</a>
Photo: Shutterstock

Analyst Color

Health Care

Initiation

Analyst Ratings

General

ITGR

Integer Can Drive Consolidation Of Medical Device Outsourcing, Bullish Analyst Projects

MGNI

Magnite shares are trading higher after Netflix said it would launch in-house advertising technology platform by the end of 2025.

The Trade Desk shares are trading higher after Netflix said it would launch in-house advertising technology platform by the end of 2025.

Netflix Reaches 40M Global MAUs On Ad-Supported Plan; Plans To Launch In-House Advertising Technology Platform By End Of 2025

SoFi Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>), a prominent player in the online personal finance and banking sector, has been on a rollercoaster ride in the stock market over <a href="https://www.benzinga.com/quote/SOFI/news">the past year</a>.
The San Francisco-based company provides a wide array of financial products and services, including student loan refinancing, mortgages, personal loans, credit cards, investing and banking, accessible through both mobile and desktop interfaces.
<h1 class="wp-block-heading">SoFi Stock Analyst &#8216;As Bullish As Ever&#8217;</h1>
SoFi stock was recently applauded by Mizuho Securities analyst Dan Dolev. Coming out of management meetings with SoFi executives, Mizuho analysts were &#8220;as bullish as ever.&#8221;
The analyst highlighted healthy internal indicators and noted the company is being cautious about personal loan growth due to less upbeat external indicators. The DQ loan sale has strong economics, and life of loan losses are on track, despite variability from new shorter-duration loans.
Also Read: <a href="https://www.benzinga.com/news/24/04/38532031/whats-going-on-with-sofi-technologies-stock-after-earnings">What&#8217;s Going On With SoFi Technologies Stock After Earnings?</a>
<h1 class="wp-block-heading">Stock Performance Dynamic: What Do The Price Charts Say?</h1>
SoFi&#8217;s stock performance has been quite dynamic, with a 53.04% increase over the past year, contrasting with a -26.63% year-to-date decline. These fluctuations reflect the volatile nature of the market and the company&#8217;s response to various economic factors.
Let&#8217;s delve into the company&#8217;s stock price chart, and analyst ratings to understand its current position and potential for investors.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="628" height="453" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15134938/Screenshot-2024-05-15-at-6.19.38-PM.png" alt="" class="wp-image-340084" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15134938/Screenshot-2024-05-15-at-6.19.38-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15134938/Screenshot-2024-05-15-at-6.19.38-PM-300x216.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></figure>
<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Chart: Benzinga Pro</a>
The price chart analysis for SoFi stock reveals a mixed picture. The stock is currently experiencing buying pressure, with its 8-day simple moving average (SMA) at $7.18, 20-day SMA at $7.21 and the 50-day SMA at $7.30, all suggesting a bullish signal. 
However, the 200-day SMA at $8, trading above the SoFi stock price of $7.62, indicates a bearish signal.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="628" height="453" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15135228/Screenshot-2024-05-15-at-6.20.02-PM.png" alt="" class="wp-image-340089" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15135228/Screenshot-2024-05-15-at-6.20.02-PM.png 628w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15135228/Screenshot-2024-05-15-at-6.20.02-PM-300x216.png 300w" sizes="(max-width: 628px) 100vw, 628px" /></figure>
<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">Chart: Benzinga Pro</a>
Similarly, the Moving Average Convergence Divergence (MACD) indicator stands at -0.03, suggesting a bearish momentum while the Relative Strength Index (RSI) of 58.42 indicates that SoFi stock is neither overbought nor oversold.
The Bollinger Bands have SoFi stock oscillating between the upper (bullish) and lower (bearish) band, giving mixed signals. Recent stock price movements, however, indicate a surge upwards within the upper band — a positive indication.
Overall, the technical indicators remain divided in their implication for SoFi stock.
<h1 class="wp-block-heading">SoFi Analyst Sees 70% Upside Potential</h1>
Despite the mixed technical indicators, analysts seem optimistic about SoFi&#8217;s future. The <a href="https://www.benzinga.com/quote/SOFI/analyst-ratings">consensus among analysts</a> is a buy, with a price target of $8.76, implying a 9.36% upside. 
Recent analyst notes, such as one by Mizuho Securities which reiterated a buy rating with a price target of $12, implied a substantial 70% upside potential. These ratings highlight the confidence analysts have in SoFi&#8217;s growth prospects.
SoFi Technologies&#8217; stock performance reflects both market volatility and the company&#8217;s strategic decisions. While technical indicators provide a mixed outlook, analysts remain bullish on SoFi&#8217;s future, citing its prudent approach to personal loan growth and strong financial fundamentals.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38852642/wall-street-jumps-to-all-time-highs-on-soft-inflation-bond-yields-tumble-bitcoin-so">Wall Street Jumps To All-Time Highs On Soft Inflation, Bond Yields Tumble, Bitcoin Soars, Meme Stocks Face Carnage: What&#8217;s Driving Markets Wednesday?</a>
Photo: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

Technicals

Tech

Personal Finance

SOFI

Analyst Remains 'Bullish As Ever' On SoFi Stock, Despite Bearish Signals From Price Chart

Modine Manufacturing's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) short percent of float has fallen 9.63% since its last report. The company recently reported that it has 2.36 million shares sold short, which is 4.6% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.83 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Modine Manufacturing Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715800521_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Modine Manufacturing has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Modine Manufacturing's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Modine Manufacturing's peer group average for short interest as a percentage of float is 7.60%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Modine Manufacturing?

Dick's Sporting Goods's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) short percent of float has risen 5.12% since its last report. The company recently reported that it has 5.52 million shares sold short, which is 13.35% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Dick's Sporting Goods Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715800516_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Dick's Sporting Goods has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Dick's Sporting Goods's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Dick's Sporting Goods's peer group average for short interest as a percentage of float is 14.50%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Dick's Sporting Goods?

Extra Space Storage's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) short percent of float has risen 5.95% since its last report. The company recently reported that it has 4.11 million shares sold short, which is 1.96% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.98 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Extra Space Storage Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715800511_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Extra Space Storage has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Extra Space Storage's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Extra Space Storage's peer group average for short interest as a percentage of float is 4.08%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Extra Space Storage?

HC Wainwright &amp; Co. analyst Scott Buck maintains Arqit Quantum (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQQ#NASDAQ">ARQQ</a>) with a Buy and lowers the price target from $3 to $2.

Price Target

ARQQ

HC Wainwright & Co. Maintains Buy on Arqit Quantum, Lowers Price Target to $2

Prominent crypto trader DonAlt took to his social media account with candid insights, hinting at a potential market peak amid what he perceives <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38843588/millionaire-trader-up-7-figures-in-48-hours-on-gamestop-and-amc-meme-coins-on-solana">as heightened irrationality</a> and negativity.
What Happened: DonAlt voices a gut feeling that the market might have hit its peak, despite not expecting it anytime soon. He notes an unprecedented level of hate in his comments, which he views as an indicator of market sentiment. "The hate in my comments is at ATH," he observes, implying that heightened emotions often coincide with market tops.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Anyway cycle top kinda mood today Very weird I didn&#39;t think we&#39;d be even close, I&#39;ll ponder over it some more, maybe my gut is off on it this time
&mdash; DonAlt (@CryptoDonAlt) <a href="https://twitter.com/CryptoDonAlt/status/1790360059064598578?ref_src=twsrc%5Etfw">May 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He attributes this potential peak to the current state of the market, describing it as being "objectively weak while it should be strong." DonAlt argues that this combination of a weak market and high irrationality spells trouble and highlights his concern about the sophistication of market participants.
Challenging the prevailing narrative, DonAlt questions the assumption of Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;perpetual dominance alongside Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), suggesting it&#8217;s a risky strategy to solely rely on both assets. "I'm one of the few people that thinks ETH does not have to stay around forever," he says, calling out the "Buy BTC and ETH and chill" strategy as risky.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38852191/this-trader-sees-a-barbell-portfolio-of-btc-and-memes-as-most-profitable-trading-strategy">This Trader Sees A &#8216;Barbell Portfolio Of BTC And Memes&#8217; As Most Profitable Trading Strategy</a>
Why It Matters: DonAlt expresses certainty that the cycle top is in, although he acknowledges that he could be wrong. He is particularly bearish on meme coins, stating, "I&#8217;m personally convinced it&#8217;s over for memes," predicting a significant crash for this segment of the market.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I&#39;m personally convinced it&#39;s over for memes, rest of the market might get out of this ok but I&#39;m expecting memes to giga rug GL if your portfolio is in the 10th iteration of a dog or a cat
&mdash; DonAlt (@CryptoDonAlt) <a href="https://twitter.com/CryptoDonAlt/status/1790768872917742029?ref_src=twsrc%5Etfw">May 15, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He warns that the market&#8217;s current delusional state could lead to significant downsides and ponders the potential of a complacency bounce. "I&#8217;m mostly wondering how high a complacency bounce could go and whether I actually wanna fund a proper leverage account again to short it," he contemplates.
Regarding trades, DonAlt plans to short Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) range high, targeting below the range low. He also notes a bullish breakout for Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>), planning to short if it falls back into the range. He concludes, &#8220;Prefer WIF but might spread my bets,&#8221; he concludes. For Bitcoin, Donalt <a href="https://twitter.com/CryptoDonAlt/status/1790743729659138499">plans</a> to &#8220;short with size&#8221; if it reaches his original top target of $80,000 to $90,000 or buy in case it &#8220;nukes.&#8221;
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19. 
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38843580/why-this-crypto-market-is-a-bear-trap-and-which-coins-this-trader-is-backing">Why This Crypto Market Is &#8216;A Bear Trap&#8217; And Which Coins This Trader Is Backing</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$PEPE

$WIF

Veteran Trader DonAlt Signals Potential 'Cycle Top', Says 'It's Over For Memes'

JMP Securities analyst Devin Ryan downgrades Capital Southwest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSWC#NASDAQ">CSWC</a>) from Market Outperform to Market Perform.

Downgrades

CSWC

JMP Securities Downgrades Capital Southwest to Market Perform

Macro Economic Events

Economics

Oil is trading higher following a larger-than-expected draw in US crude inventories.

Over the past 24 hours, Lido Staked Ether's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">STETH</a>) price has risen 3.8% to $2,991.94. This is contrary to its negative trend over the past week where it has experienced a 1.0% loss, moving from $3,010.63 to its current price. As it stands right now, the coin's all-time high is $4,829.57. 
The chart below compares the price movement and volatility for Lido Staked Ether over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1715799821_0.png" alt="price_chart" />
The trading volume for the coin has increased 2.0% over the past week while the overall circulating supply of the coin has increased 0.08% to over 9.37 million. The current market cap ranking for STETH is #8 at $27.97 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1715799821_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$STETH

Lido Staked Ether Up More Than 3% In 24 hours

BMO Capital&nbsp;analyst Brian Pitz reiterated&nbsp;Google&nbsp;parent&nbsp;Alphabet&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with an Outperform and a&nbsp;<a target="_blank" href="https://www.benzinga.com/quote/GOOGL/analyst-ratings" rel="noreferrer noopener">$215&nbsp;price target</a>.
The analyst said&nbsp;Google I/O contextualized&nbsp;how Alphabet will integrate and monetize over twenty years of AI initiatives and pursue the first&nbsp;big&nbsp;search&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/05/38826439/at-google-io-2024-sundar-pichai-and-team-announces-new-gemini-models-project-astra-ai-fraud-protecti" rel="noreferrer noopener">transformation in as many years with Project Astra.</a>&nbsp;
Pitz noted, specifically,&nbsp;the monetization of AI Overview improving ROAS, the cost to serve declining 80%, and Gemini integrating at the OS level across smartphones.
Bears likely argued that recent OpenAI multimodal Agent demos are more advanced, but he argued that GOOGL leverages significant scale advantages and ecosystem integration over time.
JMP Securities&nbsp;analyst Andrew Boone reaffirmed Alphabet with a Market Outperform and a $200&nbsp;price target.
With Google&#8217;s AI models able to better understand queries, respond to complex searches, and curate information for users, Boone noted Google can unlock more queries with AI-powered search. The analyst flagged that AI is significantly improving Google&#8217;s entire product suite as each of its six products with over 2 billion MAU has integrated AI features.
While he acknowledged the risk of search changing as it goes from a web crawler-based service to an AI model-powered service, which could increase competition and disrupt its distribution with partners, Google&#8217;s growing data corpus, compute infrastructure, and deep integrations with over 5 million advertisers can sustain its share of monetizable searches. 
The price target reflects Google&#8217;s vast TAM, its scale across search, video, and the cloud, and high profitability.
BofA Securities&nbsp;analyst Justin Post maintained a Buy rating on Alphabet with a price target of $200.
The Google I/O keynote was packed with announcements featuring Gemini integration across Google&#8217;s ecosystem, including Search, Workspace, Android, and Assistant, Post said. The event also included the launch of various improved LLMs and 6th-generation TPUs. 
The analyst noted that I/O supported his thesis that Google has industry-leading AI/ML capabilities, and the pace of AI innovation has accelerated. As per the analyst, Google is a net AI beneficiary, and growing generative AI (GenAI) integrations should likely drive higher usage and incremental spending across Search, Cloud, and Workspace. 
KeyBanc&nbsp;analyst Justin Patterson reiterated an Overweight rating on Alphabet with a price target of $200.
Patterson came away from Google I/O 2024 impressed by the speed at which Google has made AI accessible for consumers, enterprises, and developers (Gemini is now part of all of Google&#8217;s two billion+ user products). AI agent Astra stole the show on how GenAI is revolutionizing assistants, he said. 
Likewise, search generative experience (SGE) is now rolling out into core search as AI Overviews, which the analyst noted suggests both the user experience and cost curves are under control. 
Rosenblatt&nbsp;analyst Barton Crockett maintained a Buy rating on Alphabet with a price target of $182.
The analyst noted that Google&#8217;s two-hour I/O developer conference keynote address overviewed the widespread propagation of AI features across Google products and services. 
But, on the feature that OpenAI made the centerpiece of its 26-minute AI update presentation the day prior, which involved live audio chat and an AI model with great facility in detecting and conveying emotional tone, Alphabet&#8217;s presentation was limited, suggesting a lead for OpenAI right now in that capability. 
To his mind, this supports the notion that Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) could turn to OpenAi to help upgrade Siri and related AI features.
Stifel&nbsp;analyst maintained Alphabet with a Buy and a $196&nbsp;price target.
Price Action: GOOGL shares traded higher by 1.03% at $172.10 at the last check Wednesday.
Photo via Shutterstock

Equities

Reiteration

AAPL

GOOGL

Google Advances AI Integration, While Apple May Partner with OpenAI to Enhance Siri, Analysts Say

Analysts' ratings for IHS Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.62, a high estimate of $15.00, and a low estimate of $6.00. A 21.33% drop is evident in the current average compared to the previous average price target of $13.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1715799781_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive IHS Holding. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Colby Synesael</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Maurice Patrick</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$6.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Gregory Williams</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$15.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Eric Luebchow</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$8.50</td>
<td>$12.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to IHS Holding. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of IHS Holding compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of IHS Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of IHS Holding's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/IHS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on IHS Holding analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into IHS Holding's Background</h2>
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, most of who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.
<h3>Financial Milestones: IHS Holding's Journey</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: IHS Holding's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2023, the company experienced a revenue decline of approximately -3.11%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.
Net Margin: IHS Holding's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -93.98%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): IHS Holding's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -262.18%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -8.79%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: IHS Holding's debt-to-equity ratio surpasses industry norms, standing at 37.44. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Latest Analyst Ratings For IHS Holding

During the last three months, 9 analysts shared their evaluations of Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>), revealing diverse outlooks from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $40.11, a high estimate of $55.00, and a low estimate of $21.00. This current average reflects an increase of 7.25% from the previous average price target of $37.40. 
<img src="https://www.benzinga.com/files/images/story/2024/1715799757_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Regenxbio. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yi Chen</td>
<td>HC Wainwright &amp; Co.</td>
<td>Raises</td>
<td>Buy</td>
<td>$38.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Annabel Samimy</td>
<td>Stifel</td>
<td>Maintains</td>
<td>Buy</td>
<td>$40.00</td>
<td>-</td>
</tr>
<tr>
<td>Yi Chen</td>
<td>HC Wainwright &amp; Co.</td>
<td>Announces</td>
<td>Buy</td>
<td>$36.00</td>
<td>-</td>
</tr>
<tr>
<td>Luca Issi</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Daniil Gataulin</td>
<td>Chardan Capital</td>
<td>Maintains</td>
<td>Buy</td>
<td>$52.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Gena Wang</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$55.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Brian Skorney</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$39.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Andreas Argyrides</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$21.00</td>
<td>-</td>
</tr>
<tr>
<td>Dane Leone</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Outperform</td>
<td>$45.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Regenxbio. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Regenxbio compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Regenxbio's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Regenxbio's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RGNX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Regenxbio analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Regenxbio's Background</h2>
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
<h3>Regenxbio: Financial Performance Dissected</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Negative Revenue Trend: Examining Regenxbio's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -18.37% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.
Net Margin: Regenxbio's net margin excels beyond industry benchmarks, reaching -405.39%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Regenxbio's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -18.03%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Regenxbio's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -10.53%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a high debt-to-equity ratio of 0.22, Regenxbio faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RGNX

Evaluating Regenxbio: Insights From 9 Financial Analysts

Mizuho Securities raised the price target for&nbsp;Boston Scientific Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>), saying the cardiology segment is poised to deliver double-digit growth.
Citing the virtual NDR group meeting, Mizuho Securities Managing Director Anthony Petrone said high-level feedback suggests that the cardiology segment is poised to maintain a &#8220;healthy&#8221; double-digit top-line growth profile for the foreseeable future supported by rapid Farapulse adoption, Watchman FLX upside from combo pulsed field ablation concomitant surgery with left atrial appendage closure (PFA and LAAC) surgery, and core CRM renaissance supported by Emblem S-ICD adoption.
Related:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38411015/boston-scientific-lifts-2024-profit-forecast-on-strong-growth-from-cardiovascular-devices-stock-soa" rel="noreferrer noopener">Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars</a>.
Mizuho wrote, &#8220;Feedback supports our view that U.S. Farapulse contribution can approach our $400 million bull case scenario this year while combo PFA + LAAC surgery can drive Watchman FLX growth back over +20% heading into next year.&#8221;
With a Buy rating, Mizuho increased the&nbsp;<a href="https://www.benzinga.com/quote/BSX/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $85 to $90</a>, and cited that the scenarios from PFA and LAAC combo surgery volumes support a higher $115 bull case price target.
The analyst said the Farapulse launch in the U.S. mirrored its European rollout. Faster ablation times increased capacity by about 36%, leading to more scheduled cases.&nbsp;
The company anticipates that results from their persistent atrial fibrillation (AF) trials will boost awareness and treatment, further expanding the PFA market.
Boston Scientific anticipates substantial growth for its blockbuster product, already generating over $1 billion, with a near-term growth projection of +20% due to deeper market penetration. 
The Option trial is evaluating the Watchman device as an alternative to anticoagulation following ablation procedures. Data are expected in late 2024 or early 2025, leading to label expansion and increased use. 
The Champion trial results, expected in the first half of 2026, could further extend the product&#8217;s use to AF patients before ablation. Concerns about competition from new Factor 11 inhibitor anticoagulants seem overstated due to their uncertain efficacy, high cost and need for regular injections.
Mizuho noted, &#8220;All in, the momentum in Watchman is likely to continue for years driven by increased penetration through label expansions combined with updated guidelines and reimbursement tailwinds.&#8221;
BSX Price Action:&nbsp;Boston Scientific Corporation shares are up 0.94% at $74.18&nbsp;at last check&nbsp;Wednesday.
Photo: Shutterstock

Large Cap

Boston Scientific's Upside With Cardiology Devices Drives Momentum

Bitcoin Cash's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bch/usd">BCH</a>) price has increased 4.95% over the past 24 hours to $452.86, which is in the opposite direction of its trend over the past week, where it has experienced a 3.0% loss, moving from $460.13 to its current price. As it stands right now, the coin's all-time high is $3,785.82. 
The chart below compares the price movement and volatility for Bitcoin Cash over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1715799752_0.png" alt="price_chart" />
The trading volume for the coin has decreased 25.0% over the past week, while the overall circulating supply of the coin has increased 0.2% to over 19.71 million. This puts its current circulating supply at an estimated 93.84% of its max supply, which is 21.00 million. The current market cap ranking for BCH is #17 at $8.86 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1715799752_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$BCH

Bitcoin Cash Up More Than 4% In 24 hours

Beneficient (BENF) has issued an update. Beneficient has successfully regained compliance with Nasdaq's minimum bid price requirement, ensuring its...

Beneficient Regains Nasdaq Compliance, Boosting Market Confidence

Trupanion, Cipher Mining among financial movers

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Billing itself as a technology-enabled financial services firm, Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) captured the spotlight on Wall Street with a dramatic 390% lift on Friday before paring down some of the massive return. Initially catapulting BENF stock was news about the company meeting Nasdaq&rsquo;s minimum price rule. In addition, a framework for sparking a short squeeze could be brewing for shares.



According to a <a href="https://finance.yahoo.com/news/beneficient-regains-compliance-nasdaq-minimum-120000965.html">press release</a>, Beneficient just regained compliance regarding the minimum bid price requirement of the exchange. Rule 5550(a)(2) states that for an entity to <a href="https://listingcenter.nasdaq.com/ViewPDF.aspx?Material_Search.aspx?mcd=CD&amp;cid=14&amp;years=2017,2016,2015,2017,2016,2015,2014,2013,2012,2011,2010,2009,2008,2007,2006,2005,2004,2003,2002&amp;sub_cid=76&amp;searchkeywords=&amp;exactsearchddvalue=1&amp;Print=N&amp;materials=0&amp;popularfl=#:~:text=Rule%205550(a)(2,at%20least%20%241%20per%20share.">remain listed</a>, &ldquo;the minimum bid price per share for common stock shall be at least $1 per share.&rdquo;



With the notice, speculators have assurances that &mdash; assuming continued compliance &mdash; BENF stock will remain listed and tradeable on the exchange. For a small firm like Beneficient, a Nasdaq listing represents a true lifeblood. By being tradable on a proper exchange, Beneficient will <a href="https://www.nasdaq.com/solutions/listings/transfer-to-nasdaq#:~:text=Switching%20to%20Nasdaq%20is%20Good%20for%20Your%20Stock&amp;text=After%20making%20the%20switch%20to,%2C%20liquidity%2C%20and%20the%20close.">enjoy benefits</a> such as higher visibility and greater liquidity.



<h2>Possible Short Squeeze Brewing for BENF Stock</h2>



Another factor that could be dramatically lifting BENF stock today is the possibility of a short squeeze. To be clear, Fintel shows that the security&rsquo;s <a href="https://fintel.io/ss/us/benf">short interest</a> sits at only 2.77% of its float. That&rsquo;s not remarkable by any stretch of the imagination. However, as Benzinga alludes to, a <a href="https://www.benzinga.com/news/24/05/38618734/why-beneficient-benf-shares-are-exploding-higher">framework for a short squeeze</a> could be materializing with BENF. First, even though the short interest as of the latest read is minimal, Fintel reports that shares available to be shorted at a leading prime brokerage slipped to zero just hours ago. That said, this metric is not based off an all-encompassing count, so traders should be careful with their interpretation of the data.



Nevertheless, the second point here is particularly intriguing: The shares outstanding count for BENF stock is only 3.36 million, with the float (shares available for public trading) sitting at 1.1 million. With 64.45% of shares held by insiders and 20.51% held by institutions, per Yahoo Finance, the ability to bet against Beneficient is limited.



Not only that, Fintel reports that the short borrow fee for those who do wish to bet against BENF stock recently soared to 526.49%. Back on April 22, this metric was &ldquo;only&rdquo; 20.19%.



<h2>Why It Matters</h2>



Although a short squeeze could send BENF stock even higher than where it currently stands, context matters. Even with today&rsquo;s blistering run, Beneficient is down 83% in the charts since the beginning of the year. Further, Gurufocus points out that the company incurred a <a href="https://www.gurufocus.com/stock/BENF/financials">retained loss</a> of nearly $2 billion as of December 2023.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</a>



On the date of publication, Josh Enomoto did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-beneficient-benf-stock-up-390-today/">Why Is Beneficient (BENF) Stock Up 390% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Beneficient (BENF) Stock Up 390% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Monday!



Moving stocks this morning are acquisition agreements, delisting updates, earnings reports, results from a clinical trial and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Strong Global Entertainment (NYSEMKT:<a href="https://investorplace.com/stock-quotes/sge-stock-quote/">SGE</a>) stock is rocketing more than 73% after <a href="https://www.nasdaq.com/press-release/fg-acquisition-corp.-announces-proposed-acquisition-of-strong-mdi-screen-systems-inc.">announcing an acquisition</a> deal for Strong/MDI Screen Systems.</li>



<li>Perficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/prft-stock-quote/">PRFT</a>) shares are soaring over 52% on a <a href="https://www.nasdaq.com/press-release/perficient-to-be-acquired-by-eqt-for-approximately-%243.0-billion-2024-05-05">$3 billion acquisition agreement</a>.</li>



<li>Beneficient (NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) stock is surging more than 30% as it continues to rally after <a href="https://investorplace.com/2024/05/why-is-beneficient-benf-stock-up-390-today/">regaining Nasdaq compliance</a>.</li>



<li>Holdco Nuvo Group DG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVO#NASDAQ">NUVO</a>) shares are gaining close to 26% alongside heavy pre-market trading.</li>



<li>Ohmyhome (NASDAQ:<a href="https://investorplace.com/stock-quotes/omh-stock-quote/">OMH</a>) stock is increasing over 25% with strong early morning trading.</li>



<li>Graphex (NYSEMKT:<a href="https://investorplace.com/stock-quotes/grfx-stock-quote/">GRFX</a>) shares are rising more than 20% on Monday morning with heavy trading.</li>



<li>Kuke Music (NYSE:<a href="https://investorplace.com/stock-quotes/kuke-stock-quote/">KUKE</a>) stock is climbing 15% without any clear news this morning.</li>



<li>MagnaChip Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/mx-stock-quote/">MX</a>) shares are heading almost 14% higher after <a href="https://www.msn.com/en-us/money/markets/mx-stock-earnings-magnachip-semiconductor-beats-eps-beats-revenue-for-q1-2024/ar-AA1o3Wvk?ocid=finance-verthp-feeds">beating Q1 estimates</a>.</li>



<li>XBP Europe (NASDAQ:<a href="https://investorplace.com/stock-quotes/xbp-stock-quote/">XBP</a>) stock is jumping over 13% despite a lack of news today.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) shares are up more than 12% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>GlycoMimetics (NASDAQ:<a href="https://investorplace.com/stock-quotes/glyc-stock-quote/">GLYC</a>) stock is crashing over 65% after releasing <a href="https://www.nasdaq.com/press-release/glycomimetics-announces-results-of-pivotal-phase-3-study-of-uproleselan-in-relapsed">Phase 3 clinical trial results</a>.</li>



<li>Acutus Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/afib-stock-quote/">AFIB</a>) shares are plummeting more than 37% as <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318290674&amp;type=PDF&amp;symbol=AFIB&amp;cdn=6e5e582e7483b6fb995c1c182a92e5fd&amp;companyName=Acutus+Medical+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-05-03">its delisting approaches</a>.</li>



<li>Meta Materials (NASDAQ:<a href="https://investorplace.com/stock-quotes/mmat-stock-quote/">MMAT</a>) stock is diving over 27% on plans to <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318290809&amp;type=PDF&amp;symbol=MMAT&amp;cdn=0035f13ac51900fd0da1cc198df775b6&amp;companyName=Meta+Materials+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-05-03">lay off 80% of its employees</a>.</li>



<li>Loop Media (NYSEMKT:<a href="https://investorplace.com/stock-quotes/lptv-stock-quote/">LPTV</a>) shares are falling more than 18% after releasing its <a href="https://www.nasdaq.com/press-release/loop-media-reports-2024-fiscal-second-quarter-financial-results-2024-05-03">fiscal Q2 2024 earnings report</a>.</li>



<li>Medical Properties Trust (NYSE:<a href="https://investorplace.com/stock-quotes/mpw-stock-quote/">MPW</a>) stock is tumbling over 18% after tenant Steward Health <a href="https://www.marketwatch.com/story/medical-properties-trust-shares-drop-on-steward-health-bankruptcy-d1c76635?mod=investing">filed for bankruptcy</a>.</li>



<li>Predictive Oncology (NASDAQ:<a href="https://investorplace.com/stock-quotes/poai-stock-quote/">POAI</a>) shares are dropping more than 16% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318292604&amp;type=PDF&amp;symbol=POAI&amp;cdn=be2400ae57b9aff8b086174983e0993c&amp;companyName=Predictive+Oncology+Inc.&amp;formType=S-3&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-05-06">proposed public offering</a>.</li>



<li>Warrantee (NASDAQ:<a href="https://investorplace.com/stock-quotes/wrnt-stock-quote/">WRNT</a>) stock is taking an over 16% beating on Monday morning.</li>



<li>Benson Hill (NYSE:<a href="https://investorplace.com/stock-quotes/bhil-stock-quote/">BHIL</a>) shares are sliding more than 15% with strong trading this morning.</li>



<li>Mobile-health Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/mndr-stock-quote/">MNDR</a>) stock is decreasing over 14% today.</li>



<li>NeuBase Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nbse-stock-quote/">NBSE</a>) shares are down 13% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318290536&amp;type=PDF&amp;symbol=NBSE&amp;cdn=0bee8495da7c92b56ecafb96c97b1e73&amp;companyName=NeuBase+Therapeutics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-05-03">another delisting notice</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-6th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Strong Global&nbsp;Entertainment&nbsp;(NYSEMKT:<a href="https://investorplace.com/stock-quotes/sge-stock-quote/">SGE</a>) stock is on the rise Monday after the projection screens manufacturing company <a href="https://www.nasdaq.com/press-release/fg-acquisition-corp.-announces-proposed-acquisition-of-strong-mdi-screen-systems-inc.">announced an acquisition deal</a> with FG Acquisition.



This has special purpose acquisition company (SPAC) FG Acquisition agreeing to acquire Strong Global&nbsp;Entertainment&rsquo;s Strong/MDI Screen Systems. Following this acquisition, FG Acquisition will change its name to Saltire Holdings, Ltd.



FG Acquisition intends to rebrand to Saltire and switch focus to become an equity investment company. This will also see it enter into a management agreement with Saltire Partners, Inc.



Strong Global&nbsp;Entertainment CEO Mark Roberson, said the following about the deal.




&ldquo;MDI is a global leader in cinema and entertainment, and being part of Saltire will provide greater access to the Canadian financial markets as the management team executes on its growth plans. For Strong Global, this represents an opportunity to unlock the value of our investment in MDI and we look forward to participating in the future growth and success of Saltire.&rdquo;




<h2>How This Affects SGE Stock</h2>



Shares of SGE stock are seeing heavy trading on Monday alongside the acquisition deal. That has more than 2.6 million units changing hands as of this writing. That&rsquo;s well above Strong Global&nbsp;Entertainment&rsquo;s daily average trading volume of only about 7,800 shares.



SGE stock is up 57.9% as of Monday morning.



There are more stock market stories worth reading about below!



We have all of the hottest stock market news for Monday! That includes the biggest pre-market stock movers this morning, the latest news for Beneficient&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/benf-stock-quote/">BENF</a>) investors and more. All of that news is available at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-6th/">Today&rsquo;s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on&nbsp;Monday</a></li>



<li><a href="https://investorplace.com/2024/05/why-is-beneficient-benf-stock-up-390-today/">Why Is Beneficient (BENF) Stock Up 390% Today?</a></li>



<li><a href="https://investorplace.com/2024/05/fisker-stock-magna-says-production-of-ocean-suvs-is-idle/">Fisker Stock: Magna Says Production of Ocean SUVs Is &lsquo;Idle&rsquo;</a></li>
</ul>On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/why-is-strong-global-entertainment-sge-stock-up-58-today/">Why Is Strong Global Entertainment (SGE) Stock Up 58% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Beneficient Stock (NASDAQ:BENF), Short Interest Report

People Also Watch